^
    17d
    A Study of SHR-7367 With Anti-tumor Agents in Patients With Solid Tumors (clinicaltrials.gov)
    P1/2, N=100, Not yet recruiting, Shanghai Hengrui Pharmaceutical Co., Ltd.
    New P1/2 trial
    |
    gemcitabine • paclitaxel • AiRuiLi (adebrelimab) • SHR-7367
    4ms
    A Trial of SHR-7367 in Subjects With Advanced Solid Tumors (clinicaltrials.gov)
    P1, N=22, Active, not recruiting, Shanghai Hengrui Pharmaceutical Co., Ltd. | Recruiting --> Active, not recruiting | N=182 --> 22
    Enrollment closed • Enrollment change
    |
    SHR-7367
    over2years
    A Trial of SHR-7367 in Subjects With Advanced Solid Tumors (clinicaltrials.gov)
    P1, N=182, Recruiting, Shanghai Hengrui Pharmaceutical Co., Ltd. | Not yet recruiting --> Recruiting
    Enrollment open • Metastases
    |
    SHR-7367